Likewise, other studies have shown the same reduction in Akt phosphorylation in human glioma and neuroblastoma lines and murine astrocytes, when using a synthetic cannabinoid (WIN 55,212-2) and CBD [38,41,48]. This evidence concerns the gene AKT1 and neuroblastoma.